Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAS-102 in metastatic colorectal cancer
NCT03274882Phase 2Completed
- Sponsor
- Servier
- Start
- Mar 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trifluridine + tipiracil in metastatic colorectal cancer (mCRC), sponsored by Servier. Started Mar 2017; status: completed.
02
Drugs
trifluridine + tipiracil
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT03274882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03274882.